Summary by Moomoo AI
On April 5, 2024, Teladoc Health, Inc. announced a leadership transition with the departure of Jason Gorevic as Chief Executive Officer and from the Board of Directors. Mala Murthy, the company's Chief Financial Officer since 2019, has been appointed as the acting CEO effective immediately. Murthy's extensive experience includes her role as CFO at American Express' Global Commercial Services and various leadership positions at PepsiCo. Alongside the executive change, Teladoc Health reaffirmed its financial outlook for Q1 and the full year of 2024, consistent with the previous earnings release on February 20, 2024. The financial results for Q1 2024 are preliminary and unaudited. The company has also initiated a search for a permanent CEO with the help of an executive search firm. In her new role, Murthy's base salary will increase to approximately $750,000 with a target bonus opportunity of 120% of her base salary, and she will receive an additional annual equity grant valued at around $1,100,000. Jason Gorevic will receive separation benefits as per his employment agreement.